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Intricate interplay may exist between pre-mRNA
splicing and the cell division cycle, and fission yeast
Dsk1 appears to play a role in such a connection. Previ-
ous genetic analyses have implicated Dsk1 in the regu-
lation of chromosome segregation at the metaphase/an-
aphase transition. Yet, its protein sequence suggests
that Dsk1 may function as a kinase specific for SR pro-
teins, a family of pre-mRNA splicing factors containing
arginine-serine repeats. Using an in vitro system with
purified components, we showed that Dsk1 phosphoryl-
ated human and yeast SR proteins with high specificity.
The Dsk1-phosphorylated SF2/ASF protein was recog-
nized strongly by a monoclonal antibody (mAb104)
known to bind the in vivo phosphoepitope shared by SR
proteins, indicating that the phosphorylation sites re-
sided in the RS domain. Moreover, the fission yeast
U2AF65 homolog, Prp2/Mis11 protein, was phosphoryl-
ated more efficiently by Dsk1 than by a human SR pro-
tein-specific kinase, SRPK1. Thus, these in vitro results
suggest that Dsk1 is a fission yeast SR protein-specific
kinase, and Prp2/Mis11 is likely an in vivo target for
Dsk1. Together with previous genetic data, the studies
support the notion that Dsk1 may play a role in coordi-
nating pre-mRNA splicing and the cell division cycle.
Many cellular processes are regulated coordinately with the
progression of the cell division cycle (e.g. Refs. 1 and 2), and
RNA splicing is likely to be included in this regulation. For
example, RNA splicing may be down-regulated in the cell when
transcription is repressed during mitosis and up-regulated
when RNA precursors are produced actively during cell growth
(3). Indeed, evidence indicates that the pre-mRNA splicing
apparatus is disassembled during mitosis and has to be reas-
sembled when cells exit mitosis (4). Because protein phospho-
rylation is involved in the regulation of virtually every aspect of
cellular processes (5, 6), we decided to look for protein kinases
in fission yeast which are involved in regulating splicing during
the cell cycle. The Dsk1 kinase in Schizosaccharomyces pombe
is an excellent candidate because it has a role in cell cycle
progression (7), and it is homologous to a human SR protein
kinase (8). Compared with budding yeast, fission yeast (S.
pombe) has the advantage of being more similar to higher
eukaryotes especially with regard to the appearance of introns
in protein-encoding genes (9–11).
The dsk11 gene was originally identified as a multicopy
suppressor of cold-sensitive dis1 mutants (7). dis1 mutants are
defective in sister chromatid separation at the restrictive tem-
perature, and mitosis never reaches completion in these mu-
tants (12). The Dis1 protein is associated with microtubules
and the spindle pole body and probably is phosphorylated by
Cdc2 kinase (13). dsk11 gene is not essential for viability,
probably because of a redundancy in its function in fission
yeast, but overexpression of dsk11 results in a delay at the
G2/M phase transition (7). dsk1
1 encodes a 61-kDa protein
kinase, but its in vivo substrate has yet to be identified. Al-
though dis1 mutants are suppressed by increasing the expres-
sion level of dsk11 (7), the Dis1 protein is unlikely as a sub-
strate for the Dsk1 kinase because dsk11 also suppresses a null
allele of dis1.1 Dsk1 itself becomes highly phosphorylated at
mitosis, and the Dsk1 protein isolated from mitotic cells is more
active in phosphorylating myelin basic protein (MBP)2 in vitro
(7). Interestingly, the localization of Dsk1 is also cell cycle-de-
pendent; Dsk1 is localized in the cytoplasm during interphase,
but it is found mostly in the nucleus at mitosis. Hence the Dsk1
protein may play a role in mitotic control by altering its cellular
location and its target proteins.
The sequence similarity between Dsk1 and human SRPK1
(SR protein kinase 1) suggests that the in vivo substrates for
Dsk1 may be proteins containing serine/arginine repeats.
SRPK1 specifically phosphorylates a family of pre-mRNA splic-
ing factors called SR proteins, at their arginine/serine-rich
domain, the RS domain (8, 14). SR proteins are involved in
constitutive splicing (15, 16) as well as being specific modula-
tors in alternative splicing (17). In vivo, SR proteins are phos-
phorylated, predominantly on serine residues in the RS domain
(18, 19). The phosphorylation of SR proteins apparently is not
only important for the splicing reaction itself but also affects
the location of the SR proteins within the nucleus. A cycle of
phosphorylation-dephosphorylation of splicing factors is neces-
sary for splicing to take place (20, 21). The stage-dependent
sensitivity of pre-mRNA splicing to phosphatases and phospha-
tase inhibitors observed in mammalian nuclear extracts may
simply reflect the dynamics in differential phosphorylation of
SR proteins in one round of the splicing reaction. Recent evi-
dence demonstrates that phosphorylation of SR proteins en-
hances protein-protein interactions while also inhibiting non-
specific interactions with RNA (22). The phosphorylation cycle
of splicing factors is reminiscent of the mutually antagonistic
kinase and phosphatase systems operating cell cycle control
(23, 24). Thus, the cellular localization and possibly the activity
of SR proteins are regulated during the cell cycle by their
phosphorylation status in a stage-specific manner (4).
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Prp2 protein is the only SR-like protein identified so far
which is required for pre-mRNA splicing in S. pombe. The
prp21 gene encodes a homolog of the 65-kDa subunit of human
splicing factor U2AF (25), and human U2AF65 protein is a good
substrate for SRPK1 in vitro (8). A prp2 mutant was identified
initially as a temperature-sensitive mutant defective in
pre-mRNA splicing (26). Interestingly, another prp2 mutant
allele, mis11-453, was isolated by a screen for mutants im-
paired in chromosome segregation with a high rate of minichro-
mosome loss (27). Progression through G1 and G2 phases is
blocked in mis11 mutant cells which leads to reduced cell size.
Thus, the Prp2/Mis11 protein is a very attractive candidate as
a substrate for Dsk1.
The fission yeast Dsk1 protein is of particular interest be-
cause of its possible function in coordinating pre-mRNA splic-
ing with the progression of the cell division cycle. It may pro-
vide a model system to unravel, at the molecular level, the
mechanism for synchronous regulation between pre-mRNA
splicing and the cell division cycle. To determine whether Dsk1
is a functional homolog of human SRPK1 in fission yeast, we
purified recombinant Dsk1 and various SR proteins to charac-
terize the kinase properties of Dsk1. Using a cell-free assay we
established biochemically that Dsk1 is an SR protein-specific
kinase in fission yeast. The results also provided the first
evidence that the essential splicing factor in S. pombe, the
Prp2/Mis11 protein, is likely an in vivo target for Dsk1 func-
tion. Our studies, combined with the previous genetic data,
suggest that Dsk1 may be a dual functional protein involved in
both pre-mRNA splicing and the cell division cycle.
EXPERIMENTAL PROCEDURES
Plasmid Construction—To construct pET-28a dsk11 encoding Dsk1
with a histidine tag at the NH2 terminus, a fragment of 340 base pairs
from the 59-portion of dsk11 (7) was synthesized using two primers
(59-GCCAGCCATGGATCCATGGGAAGTG-39, including a BamHI site,
and 59-GGCAGCTCGATCATATGCAAGCCAAAC-39, including the
unique internal NdeI site) in a polymerase chain reaction (28). The
polymerase chain reaction fragment was inserted into the PCR II vector
(Invitrogen). The NdeI-EcoRV fragment of 1,400 base pairs from
pDS113-6 (7), including the remainder of dsk11, was added to regener-
ate the entire dsk11 coding sequence. The BamHI/NotI fragment con-
taining the constructed dsk11 was then inserted into pET-28a (Nova-
gen) to generate pET-28a dsk11. To construct pET-28b GST-prp21
encoding Prp2 fused at the COOH terminus of glutathione S-transfer-
ase (GST), the NcoI-NdeI fragment in pET-28b (Novagen) containing
the histidine tag was replaced by the GST sequence from pET-14b
GST-SF2/ASF (from Xiang-Dong Fu). An NdeI-BamHI fragment con-
taining the prp21 sequence in pPrp2/RK171a (from Judith Potashkin)
was then inserted to generate pET-28b GST-prp21.
Production and Purification of Recombinant Proteins—Escherichia
coli strain BL21(DE3)pLysS (29) carrying the plasmid of interest was
grown to an A600 of 0.3–0.5 at 37 °C in LB containing 30 mg/ml chlor-
amphenicol plus 30 mg/ml kanamycin for pET-28a dsk11 and pET-28b
GST-prp21 or plus 50 mg/ml carbenicillin for pET-14b GST-SF2/ASF.
The culture was induced in the presence of 0.4 mM isopropyl b-D-
thiogalactopyranoside at 30 °C for 3 h (30). Cells were then centrifuged
and washed with buffer A (10 mM Tris-HCl, pH 7.4, 100 mM NaCl, 1 mM
MgCl2, 1 mM b-mercaptoethanol for histidine-tagged proteins or 1 mM
dithiothreitol for GST fusion proteins). The cell pellet was resuspended
at ;0.1 g of cells/ml or ,1010 cells/ml in buffer B (50 mM Tris-HCl, pH
7.4, 100 mM NaCl, 5% glycerol, 5 mM EGTA for histidine-tagged pro-
teins or 2 mM EDTA for GST fusion proteins, 1 mM b-mercaptoethanol
for histidine-tagged proteins or dithiothreitol for GST fusion proteins)
plus protease inhibitors (5 mg/ml of pepstatin, 5 mg/ml of chymostatin,
5 mg/ml of leupeptin, 1 mM phenylmethylsulfonyl fluoride, and 25 mg/ml
aprotinin). The cells were lysed by repetitive freezing and thawing
followed by sonication using a sonicator (Polytron, Kinematica AG,
Switzerland) for 30 s at setting 5. The lysate was centrifuged at 15,000
rpm for 15 min in an SA600 rotor (Sorvall) to separate the soluble
fraction (supernatant) and inclusion bodies (pellet). The inclusion bod-
ies were washed in buffer A, suspended in buffer B containing 1%
Nonidet P-40 and the protease inhibitors (at 20–30 mg of the starting
cell mass/ml of buffer), and sonicated.
His6-Dsk1 was purified from the soluble fraction by nickel-IDA aga-
rose chromatography (31), whereas GST fusion proteins were purified
from both soluble and inclusion body fractions by glutathione-agarose
chromatography (32). IDA Sepharose Fast Flow (Pharmacia Biotech
Inc.) was charged with 100 mM nickel chloride for 10 min at room
temperature and washed extensively with water. The soluble fraction
containing His6-Dsk1 was incubated with the nickel-IDA beads at 4 °C
for 1 h with constant agitation in the presence of 5 mM EGTA and 10 mM
imidazole. The protein-bound beads were packed in a column and
washed with TBS (10 mM Tris-HCl, pH 7.4, 150 mM NaCl) containing 5
mM EGTA, 20 mM imidazole, and 0.1–0.5% Nonidet P-40. Nonidet P-40
was omitted during the final wash, and His6-Dsk1 was eluted from the
column in TBS containing 150–200 mM imidazole. Similarly, GST fu-
sion proteins were bound to glutathione-agarose beads, washed with
TBS, and eluted in TBS containing 5 mM glutathione. Purified proteins
were aliquotted, frozen in liquid nitrogen, and stored at 280 °C.
SRPK1 was a gift of Xiang-Dong Fu. SF2/ASF, SF2DRS, SRp30c,
SRp40, SRp55, and Npl3 were gifts of Adrian Krainer.
Antibodies—A peptide corresponding to the COOH-terminal end of
Dsk1, ATGEDVPGWATEIR, was conjugated to keyhole limpet hemo-
cyanin, and the conjugate was used for immunization of rabbits (33).
The anti-peptide antibodies were purified by affinity chromatography
using the peptide coupled to Affi-Gel 15 resin (Bio-Rad) (34). mAb104
was isolated from hybridoma cells (American Type Culture Collection
CRL 2067) (33). Anti-GST polyclonal antibodies were from Santa Cruz
Biotechnology. Anti-SF2/ASF monoclonal antibody was from Adrian
Krainer.
Kinase Assay—Purified kinase was incubated at 23 °C for 30 min
with the substrate in a total volume of 20 ml containing a kinase buffer
(50 mM Tris-HCl, pH 7.4, 10 mM MgCl2, 1 mM dithiothreitol) in the
presence of 50 mM ATP and 2 mCi of [g-32P]ATP. The kinase reaction
was terminated by boiling in SDS sample buffer, and the sample was
resolved on a 10% or 12% SDS-polyacrylamide gel. Protein phosphoryl-
ation was detected by autoradiography. For Western blot analysis, the
kinase reaction was performed by employing an ATP-regenerating sys-
tem (10 mM creatine phosphate, 1 mM ATP, and 0.1 mg/ml creatine
phosphokinase) without radioisotopes. Immunoblotting was performed
as described (33, 35).
RESULTS
The Dsk1 Kinase Has Distinct Substrate Specificity for SR
Proteins—Full-length Dsk1 protein was produced as a fusion
construct with an NH2-terminal tag of 6 histidine residues
(designated His6-Dsk1) in E. coli. The histidine-tagged Dsk1
protein in the soluble fraction of the bacterial lysate was bound
to nickel-IDA agarose and eluted with buffers containing 150–
200 mM imidazole. The His6-Dsk1 protein was recognized by
polyclonal antibodies against its COOH-terminal peptide (AT-
GEDVPGWATEIR) as a 65-kDa protein (data not shown).
To assess whether the purified fusion His6-Dsk1 protein was
catalytically active, we examined whether it was capable of
phosphorylating MBP. Dsk1 was incubated with MBP in the
presence of [g-32P]ATP in a kinase buffer. As detected by gel
electrophoresis and autoradiography, we observed that MBP
was phosphorylated by the His6-Dsk1 (data not shown, but see
Fig. 1, lane 10). Autophosphorylation of Dsk1 itself was de-
tected after a longer exposure of the gel to x-ray film (data not
shown; but see Fig. 2, lane 3), although the phosphorylation
signal was much weaker than that of MBP. Both observations,
which are consistent with our previous studies (7), indicate
that the purified His6-Dsk1 is active as a kinase.
The protein sequence of Dsk1 suggests that it is homologous
to human SRPK1, which is an SR protein-specific kinase (8). To
test the functional similarity between the two proteins, we
compared the substrate specificity between Dsk1 and SRPK1
in a cell-free kinase assay. As a reference, Xenopus Cdc2-
human cyclin B complex (Cdc2-cyclin B) was used in parallel
for comparison because all three kinases belong to a superfam-
ily of serine/threonine-specific kinases (7, 8, 36). Cdc2-cyclin B
complex is known as the maturation-promoting factor or the
major M phase cyclin-dependent kinase for its function in in-
ducing mitosis (37, 38). SR proteins are phosphoproteins in vivo
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and contain Cdc2 phosphorylation consensus sequences, (S/T)-
P-X-(R/K); however, none of the SR proteins tested so far is an
in vitro substrate for Cdc2 (8). Instead, SR proteins are phos-
phorylated by human SRPK1 and Clk/Sty in a highly specific
and efficient manner (39, 40). Four proteins were tested as
substrates in our assay: human SF2/ASF as an SR protein
(39–41) in the form fused with GST (GST-SF2/ASF), bovine
MBP, histone H1, and casein as serine/threonine-containing
polypeptides. Histone H1 is typically used as a standard sub-
strate for assaying the kinase activity of maturation-promoting
factor (42). As expected, MBP, histone H1, and casein served as
good substrates for the Cdc2-cyclin B complex (Fig. 1, lanes
14–16), whereas GST-SF2/ASF was not phosphorylated by
Cdc2-cyclin B (Fig. 1, lane 13). In contrast, SRPK1 and His6-
Dsk1 did not act on histone H1 or casein (Fig. 1, lanes 7, 8, 11,
and 12). Dsk1 displayed a relatively moderate kinase activity
toward MBP (Fig. 1, lane 10) compared with SRPK1 (lane 6) or
Cdc2-cyclin B (lane 14). Importantly, His6-Dsk1 phosphoryl-
ated GST-SF2/ASF protein very well (Fig. 1, lane 9), as did
SRPK1 (lane 5). The specificity of SRPK1 and Dsk1 for GST-
SF2/ASF is significant considering that GST-SF2/ASF (0.37
mM) was present at a level that was at least 20-fold less than
the other three polypeptides (;10 mM). Note that the concen-
trations of SF2/ASF and the other three substrates used in the
assay are based on the standard assay conditions described
previously (42, 43).
To examine further the specific activity of the Dsk1 kinase,
we extended the list of substrates and included four additional
human SR proteins in our assay (SF2/ASF, SRp30c, SRp40,
and SRp55) (44). His6-Dsk1 phosphorylated SF2/ASF, SRp40,
and SRp55 (Fig. 2, lanes 8, 11, and 12). In agreement, SRPK1
also phosphorylated SF2/ASF and SRp40 (Fig. 2, lanes 4 and 7).
Interestingly, both kinases displayed very little activity toward
SRp30c (Fig. 2, lanes 6 and 10). These results indicated the
similarity between the two kinases in their substrate specific-
ity. When SRp40 was used as substrate, an additional phos-
phorylated protein was detected which migrated in the gel
considerably slower than SRp40 itself (Fig. 2, lanes 7 and 11).
The nature of this high molecular weight protein is not clear.
However, because SR proteins tend to aggregate without being
phosphorylated (39), and the size of the slow migrating protein
was about twice that of the recombinant SRp40, one likely
explanation is that it might result from the association of two
SRp40 proteins. The SRp55 used was a truncated version iso-
lated from E. coli, which was missing a portion of its COOH-
terminal domain (44). In addition to mammalian SR proteins,
we also tested an SR protein from budding yeast Saccharomy-
ces cerevisiae, Npl3 (39). As presented in Fig. 2, Npl3 is also a
good substrate for His6-Dsk1 (lane 13). In vivo the majority of
SR protein phosphorylation occurs on the serine residues in the
RS domain (40). To test the importance of the RS domain for
phosphorylation by Dsk1, a recombinant SF2/ASF with the RS
region deleted (SF2DRS) was also used in the kinase assay (Fig.
2, lane 9). SF2DRS was not phosphorylated by SRPK1 (Fig. 2,
lane 5; see Ref. 43). The level of phosphorylation by Dsk1 was
reduced drastically to a barely detectable level when the RS
region was deleted from SF2/ASF (Fig. 2, compare lanes 8 and
9). These results show that phosphorylation by Dsk1 requires
an arginine/serine-rich region on the protein substrate.
Phosphorylation by Dsk1 Generates a Phosphoepitope Shared
by Native SR Proteins—We showed above that Dsk1 phospho-
rylated various SR proteins having budding yeast to human
origins with a specificity and efficiency similar to human
SRPK1. SRPK1, as well as Clk/Sty, not only phosphorylates
serine in the RS domain in vitro, but also the pattern of phos-
phorylation closely resembles that occurring in vivo (19). A
unique feature of the phosphorylation by SRPK1 or Clk/Sty is
the formation of a phosphoepitope within the RS domain, which
can be recognized by mAb104 monoclonal antibody, which was
found originally to recognize a specific phosphoepitope present
in native SR proteins isolated from mammalian cells (45). To
provide further direct biochemical evidence that Dsk1 is an SR
protein-specific kinase, we asked whether Dsk1 produces the
mAb104-reactive phosphoepitope upon phosphorylating SR
proteins. In the experiment depicted in Fig. 3A, SF2/ASF or
SF2DRS was incubated with Dsk1 or SRPK1 in the presence of
an ATP-regenerating system. The samples were then analyzed
by Western blotting with anti-Dsk1 antibody (Fig. 3A, top pan-
el), mAb104 antibody (middle panel), or anti-SF2/ASF antibody
(bottom panel) (lanes 5–8). Control samples were also analyzed
in parallel (Fig. 3A, lanes 1–4). Note that probing the samples
with anti-SF2/ASF antibody revealed that phosphorylation of
SF2/ASF by both kinases caused a slight up-shift in gel mobil-
FIG. 1. Comparison of substrate specificity among SRPK1,
Dsk1, and Cdc2 protein kinases. Purified SRPK1 (lanes 5–8), His6-
Dsk1 (lanes 9–12), or Cdc2-cyclin B complex (lanes 13–16) was incu-
bated with GST-SF2/ASF (lanes 5, 9, and 13), MBP (lanes 6, 10, and 14),
histone H1 (lanes 7, 11, and 15), or casein (lanes 8, 12, and 16) in the
presence of [g-32P]ATP at 23 °C for 30 min. Samples were resolved on a
12% SDS-polyacrylamide gel and visualized with x-ray film. GST-SF2/
ASF was added to a final concentration of 0.37 mM, whereas MBP,
histone H1, or casein was present at 10 mM.
FIG. 2. Phosphorylation of various SR proteins by Dsk1 ki-
nase. SRPK1 (lanes 4–7) or His6-Dsk1 (lanes 8–13) was incubated with
various SR proteins, and samples were processed as described in Fig. 1.
SF2/ASF protein was used as a positive control (lanes 4 and 8). SRp30c
(lanes 6 and 10), SRp40 (lanes 7 and 11), SRp55 (lane 12), and SF2DRS
(lanes 5 and 9) were tested at 0.5 mM. Budding yeast Npl3 (lanes 13 and
19) was tested at 1 mM. Each protein incubated without kinase served as
a negative control (lanes 1–3 and 14–19).
Dsk1 Is an SR Protein Kinase in S. pombe 5965
 at CLAREM
O
NT CO
LLEG
E on June 3, 2009 
w
w
w
.jbc.org
D
ow
nloaded from
 
ity (Fig. 3A, bottom panel, lanes 5 and 7). Only two reactions in
which full-length SF2/ASF was incubated with either SRPK1
or His6-Dsk1 resulted in the formation of an mAb104-reactive
signal (Fig. 3A, lanes 5 and 7). Neither the unphosphorylated
SF2/ASF (Fig. 3A, middle panel, lane 4) nor the SF2DRS incu-
bated with either kinase (lanes 6 and 8) was recognized by
mAb104. Thus, the phosphoepitope generated by Dsk1 resided
in the RS domain and was the same as that formed by SRPK1.
These results allow us to argue strongly that Dsk1 is an SR
protein-specific kinase in fission yeast.
To show further that the recognition of SF2/ASF by mAb104
antibody is Dsk1-dependent, various amounts of Dsk1 protein
(1, 5, or 50 units with 1 unit being 0.4 pmol) were incubated
with SF2/ASF in a 20-ml kinase reaction; the samples were
then analyzed by Western immunoblotting (Fig. 3B, lanes 3–5).
A concentration as low as 0.02 mM His6-Dsk1 was sufficient to
generate the mAb104-reactive phosphoepitope (Fig. 3B, lane 5,
bottom panel), and the signal was increased substantially with
the concentration of Dsk1 at 0.1 mM (lane 4). No further in-
crease in intensity was observed when the concentration of
His6-Dsk1 went up to 1 mM (Fig. 3B, lane 3, bottom panel)
probably because of the limited amount of GST-SF2/ASF pro-
tein used in the assay (0.74 mM). Nevertheless, these results
clearly show that the recognition of SF2/ASF protein by
mAb104 antibody is Dsk1-dependent, and the extent of reac-
tion is proportional to the amount of Dsk1 protein.
In summary, we have demonstrated using an in vitro system
with purified components that the fission yeast Dsk1 has a
kinase activity similar to that of human SRPK1. These data
have provided the first direct biochemical evidence that Dsk1
specifically phosphorylates SR proteins in a fashion that closely
resembles the phosphorylation of native SR proteins in mam-
malian cells. On the basis of these findings, we have estab-
lished in vitro that Dsk1 is indeed a functional homolog of
human SRPK1 in fission yeast.
Dsk1 Phosphorylates the Fission Yeast Prp2 Protein in
Vitro—What is the in vivo target for Dsk1 in fission yeast? So
far, Prp2 is the only protein identified in fission yeast which
contains an RS domain and functions in pre-mRNA splicing
(39). The protein sequence of Prp2 bears extensive similarity to
mammalian splicing factor U2AF65 (25). The human U2AF65
has been shown to be a good substrate for both SRPK1 and
Clk/Sty in vitro (8, 19). Therefore, we decided to test the phos-
phorylation of Prp2 protein by Dsk1 using the cell-free kinase
assay system. Unlike the recombinant His6-Dsk1 and GST-
SF2/ASF proteins, the expression level of recombinant Prp2
protein in E. coli was quite low (Fig. 4B, lanes 3 and 4). Thus,
we examined whether the unpurified fission yeast Prp2 protein
in the bacterial lysate could be phosphorylated by Dsk1. Ly-
sates (soluble and inclusion body fractions) from bacteria trans-
formed with a plasmid encoding the prp21 gene or the vector
alone were incubated separately with SRPK1 (Fig. 4A, lanes
4–7) or His6-Dsk1 (lanes 10–13) in the presence of [g-32P]ATP.
A phosphorylated protein with the apparent molecular mass
expected for Prp2 protein (;60 kDa) was observed specifically
in the lysates from the bacteria containing the prp21 gene (Fig.
4A, lanes 4, 5, 10, and 11). Two bacterial proteins (one of which
is indicated by the lower arrow in Fig. 4, A and B) were
phosphorylated independent of SRPK1 or Dsk1. Interestingly,
another bacterial protein (indicated by the top arrow in Fig. 4,
A and B) was specifically labeled with 32P upon incubation with
SRPK1 (Fig. 4A, lanes 4–7) or His6-Dsk1 (lanes 10–13). The
identity of this bacterial protein was not investigated, but it
provided an internal control for comparing the specific activity
of the two kinases: the phosphorylation intensity of the bacte-
rial protein was higher than that of Prp2 in the case of SRPK1
(Fig. 4A, lanes 4 and 5), but the intensity of the two was quite
similar in the case of Dsk1 (lanes 11 and 12). These observa-
tions suggested that Dsk1 has a higher specific activity toward
Prp2 than does SRPK1 and that Prp2 may be an in vivo
substrate for Dsk1 in fission yeast.
To confirm that the phosphorylated 60-kDa protein was in-
deed the fission yeast Prp2 protein, we constructed and puri-
fied a recombinant GST-Prp2 fusion protein from E. coli (data
not shown). Various amounts of purified GST-Prp2 protein
(5–30 nM) were incubated with an excess amount of Dsk1 (100
nM) in the kinase assay (Fig. 5, lanes 6–10). Phosphorylation of
GST-Prp2 by Dsk1 was quite efficient (phosphorylation was
detected in the presence of 5 nM Prp2; Fig. 5, lane 10), and the
level of phosphorylation increased with the increasing amount
of GST-Prp2 protein used (lanes 6–10). In addition, the phos-
phorylation of Prp2 by Dsk1 was more efficient than that of
SF2/ASF by Dsk1: the phosphorylation intensity of Prp2 at 25
nM concentration (Fig. 5, lane 7) was stronger than that of
FIG. 3. Dsk1-mediated phosphorylation of SF2/ASF protein
generates the phosphoepitope specifically recognized by mono-
clonal antibody mAb104. Panel A, SRPK1 (lanes 5 and 6) or His6-
Dsk1 (lanes 7 and 8) was incubated with SF2/ASF (lanes 5 and 7) or
SF2DRS protein (lanes 6 and 8) in the presence of an ATP-regenerating
system for 30 min at 23 °C. The samples were immunoblotted with
anti-Dsk1 antibodies (top panel), mAb104 antibody (middle panel), and
anti-SF2/ASF antibody (bottom panel). 125I-Protein A, 125I-labeled
sheep anti-mouse antibodies, and alkaline phosphatase-conjugated
goat anti-mouse IgG antibodies were used as the secondary antibodies
in each panel, respectively. SF2/ASF was also incubated with a lysate
from bacteria without plasmid (lane 4) to serve as a negative control.
Panel B, different amounts of His6-Dsk1 protein (lanes 3–5) were added
to the kinase reaction as in panel A to determine the linearity of the
Dsk1 action. GST-SF2/ASF was incubated with 0.02 mM (1 unit, lane 5),
0.1 mM (5 units, lane 4), or 1 mM (50 units, lane 3) His6-Dsk1 protein.
The activity of Dsk1 was measured by immunoblotting with Anti-Dsk1
antibodies and alkaline phosphatase-conjugated goat anti-rabbit anti-
bodies (top panel) and mAb104 antibody and alkaline phosphatase-
conjugated goat anti-mouse IgG (bottom panel).
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SF2/ASF at 60 nM.
Taken together, we showed that Dsk1 displayed higher ki-
nase activity than human SRPK1 in phosphorylating Prp2, and
Prp2 protein was phosphorylated by Dsk1 more effectively
than SF2/ASF by Dsk1. In fact, Prp2 was the best substrate for
Dsk1 among the variety of SR proteins tested in the in vitro
assay system. These results are consistent with the notion that
Dsk1 may directly act on Prp2 protein in vivo.
DISCUSSION
In this study, we have purified recombinant forms of both
Dsk1 and Prp2/Mis11 proteins of fission yeast S. pombe and
characterized the potential biochemical pathway linking these
two proteins. Using a cell-free assay, we have demonstrated
that Dsk1 phosphorylates SR proteins with high specificity,
and Prp2 is the best substrate among various SR proteins
tested. This study has provided the first molecular evidence
that Dsk1 is an SR protein kinase in fission yeast. These data
also reveal the possible role of Dsk1 in vivo and suggest that
Dsk1 may act directly on Prp2 protein by phosphorylation, thus
affecting pre-mRNA splicing. In addition to its mitotic role in
cell cycle regulation implicated by previous genetic studies, our
results argue that Dsk1 may have dual functions in both
pre-mRNA splicing and the cell division cycle.
Interestingly, many observations indicating the possible in-
terplay between pre-mRNA splicing and the cell division cycle
are obtained in fission yeast, more so than in budding yeast (for
discussion, see Refs. 11 and 46). Out of 14 pre-mRNA process-
ing (prp) mutants so far identified in fission yeast, 12 of them
exhibit a cell division cycle (cdc) phenotype (11). One remark-
able example is the two allelic genes, cdc28 and prp8, which
were independently discovered as a cdc and a prp mutant,
respectively; yet each mutant displays both cdc and prp phe-
notypes (46). This may be attributed partly to the much higher
intron content in the genome of S. pombe than that of S.
cerevisiae (11). It is not surprising therefore that any abnor-
mality in pre-mRNA splicing or in the regulation of pre-mRNA
splicing may be manifested in fission yeast more readily than
in budding yeast. Additionally, progression through the cell
division cycle in fission yeast can be monitored easily by the
size of the cell; therefore, perturbations in the cell cycle control
points, particularly the G2/M phase transition, can be conve-
niently identified.
Although the present investigation has established that the
fission yeast Dsk1 protein functions as an SR protein-specific
kinase in vitro, several important questions remain to be ad-
dressed. What are the physiological consequences of the phos-
phorylation by Dsk1 in pre-mRNA splicing and cell cycle con-
trol? Is the role of Dsk1 protein in cell cycle regulation executed
through the splicing pathway or by acting directly on the cell
cycle control system at metaphase?
To answer these questions, it is necessary to determine in
vivo targets of Dsk1 protein in fission yeast. Although dis1
mutants are suppressed by increasing the expression level of
dsk11 (7), the Dis1 protein is unlikely to be a substrate for the
Dsk1 kinase because dsk11 also suppresses a null allele of
dis1.1 It is interesting to note that an intron is present in the
dis1 gene (13). On the other hand, the Prp2/Mis11 protein is a
very attractive candidate as an in vivo substrate for Dsk1.
Besides being phosphorylated in vitro by Dsk1 with high spec-
ificity based on our biochemical data, Prp2/Mis11 protein also
FIG. 4. Dsk1 protein specifically phosphorylates fission yeast
Prp2 protein. Panel A, SRPK1 (lanes 2–7) or His6-Dsk1 (lanes 8–13)
was incubated with lysates from bacteria carrying pRK171a (lanes 6, 7,
12, and 13) or pPRP2/RK171a encoding Prp2 (lanes 4, 5, 10, and 11) in
the presence of [g-32P]ATP at 23 °C for 30 min. Samples were separated
on a 10% SDS-polyacrylamide gel and processed as in Fig. 1. Phospho-
rylation of purified GST-SF2/ASF by SRPK1 or His6-Dsk1 was used as
a positive control (lanes 3 and 9). Both soluble (lanes 4, 6, 10, 12, 14, and
16) and inclusion body fractions (lanes 5, 7, 11, 13, 15, and 17) of the
lysate were used. SRPK1 and His6-Dsk1 were omitted to monitor ac-
tivities of bacterial endogenous kinases (lanes 14–17). The top arrow
indicates the phosphorylation of one unidentified bacterial protein by
SRPK1 or His6-Dsk1, and the lower arrow points to a bacterial protein
that was phosphorylated by endogenous kinases. Panel B, expression of
Prp2 protein in bacteria. Both soluble (lanes 1 and 3) and inclusion body
fractions (lanes 2 and 4) of the lysate in panel A were subjected to
electrophoresis on a 10% SDS-polyacrylamide gel and were stained with
Coomassie Blue. Arrows indicate the putative bacterial proteins phos-
phorylated in panel A.
FIG. 5. Kinase activity of Dsk1 on purified GST-Prp2 protein.
Dsk1 protein phosphorylates purified GST-Prp2 protein with high spec-
ificity and efficiency. His6-Dsk1 was incubated with GST-SF2/ASF
protein (60 nM, lane 5) or purified GST-Prp2 protein at 30 nM (lane 6),
25 nM (lane 7), 15 nM (lane 8), 10 nM (lane 9), and 5 nM (lane 10). The
experiment was performed as described in Fig. 1, and the phosphoryl-
ation was detected by autoradiography.
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seems to possess a dual functional feature with respect to its
role in both pre-mRNA splicing and the cell division cycle (see
the Introduction). Although prp21 and mis111 are in the same
gene, a gene homologous to the human splicing factor U2AF65,
the effect of the mis11-453 mutation on pre-mRNA splicing has
not been examined. To assess whether pre-mRNA splicing is
defective, the mis11 mutant was shifted to the restrictive tem-
perature, and the total RNA was isolated for Northern blot
analysis. A block of pre-mRNA splicing in the mis11 mutant
was detected3 which is similar to that observed in prp2 mu-
tants (26). Thus, the mis11-453 mutation not only causes
minichromosome loss at mitosis and cell growth block in inter-
phase (27) but also abolishes pre-mRNA splicing at the restric-
tive temperature. The splicing defect observed in mis11 mutant
cells, together with previous genetic and cellular studies, again
is consistent with our hypothesis that Dsk1 and Prp2/Mis11
protein may be interrelated in pathways connecting pre-mRNA
splicing to the cell division cycle in fission yeast. It remains to
be investigated whether there is a cause-consequence relation-
ship between splicing and chromosome loss or whether Prp2/
Mis11 uniquely has a dual role in these two cellular processes.
Could dsk1 regulate pre-mRNA splicing and cell cycle pro-
gression through a pathway other than or in addition to affect-
ing splicing activity per se? It is formally possible that an RS
domain could also exist in proteins involved in other cellular
processes in fission yeast, which are substrates for Dsk1. In-
terestingly, a large cyclophilin protein homologous to a natural
killer tumor recognition protein has been found to contain an
RS domain (47). Nonetheless, it is also conceivable that the
splicing apparatus, as an indispensable part of proper nuclear
architecture, may undergo stage-specific changes during the
cell cycle; that is, the splicing machinery may be structurally
and functionally distinct at mitosis and in the interphase. The
Dsk1 protein may facilitate these changes in a cell cycle-de-
pendent fashion. Specifically, at the metaphase/anaphase tran-
sition, Dsk1 may prepare the nuclear structure for the exit
from mitosis by interacting with factors involved in chromo-
some segregation and components of the splicing machinery.
This hypothesis would predict that if the concentration of Dsk1
protein in the cell is too high, the nuclear architecture may be
retained in the interphase configuration and consequently pre-
vent the cells from entering mitosis. Consistent with this the-
ory, overexpression of the dsk11 gene leads to a delay at G2/M
phase transition (7).
Cell viability is not affected by disruption of the dsk11 gene
(7). It may simply reflect the fact that additional protein ki-
nases exist in fission yeast with an overlapping function to
Dsk1. Four kinases involved in SR protein phosphorylation
have been identified, and two of them have been cloned (for
review, see Refs. 39 and 40). In the mammalian system, it has
been demonstrated that in addition to SRPK1, the Clk/Sty
protein (Cdc28/Cdc2-like kinase) also phosphorylates SR pro-
teins and controls the distribution of SR proteins within the
nucleus (19, 43). The Clk/Sty family of protein kinases is con-
served through evolution from yeast to human (19). The ge-
nome project of fission yeast reveals that the ka231 gene may
be one of the members of this family based on the sequence
similarity (48). Another candidate is the fission yeast Prp4
protein (49) which has been shown recently to phosphorylate
human SF2/ASF protein in vitro (50). Because Dsk1 protein
appears to be distributed in the cytoplasm during interphase
(7), a Dsk1-like kinase may localize in the nucleus to act on SR
proteins for efficient assembly of spliceosome and splicing of
pre-mRNA in interphase. On the other hand, we cannot rule
out the possibility that in interphase a small amount of Dsk1 is
present in the nucleus. In addition, Dsk1 protein is phospho-
rylated differentially during the cell cycle (7), which may exert
another level of regulation.
To investigate further the function of Dsk1, we propose as a
model that there may exist a regulatory network of protein
kinases and phosphatases to couple pre-mRNA splicing to cell
cycle control in fission yeast (Fig. 6). The network would consist
of a family of Dsk1-like kinases (Dlks) specific for SR proteins,
factors to regulate the kinases during the cell cycle, and their
substrates in pre-mRNA splicing or in the cell cycle control
pathway. As delineated briefly in the model (Fig. 6), the activ-
ity, substrate specificity, and intracellular distribution of Dsk1
may be altered by phosphorylation in a cell cycle-dependent
manner. More specifically, upon phosphorylation, Dsk1 may
favor one substrate over the other and thus, gain different or
additional functions. Dsk1 may act by phosphorylating regula-
tory and structural proteins, such as splicing factors or cell
cycle control elements, to closely coordinate pre-mRNA splicing
with the cell division cycle. This hypothesis accommodates the
possibilities that Dsk1 may have multiple substrates in vivo,
and other Dsk1-like protein kinases may exist to overlap with
Dsk1 function. New information revealing the mode of Dsk1
action will undoubtedly advance our understanding of the syn-
chronous regulation between pre-mRNA splicing and the cell
division cycle.
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